Life Saving Drugs

Brushing aside concerns of the US on India's IPR regime, the government on May 13 said its intellectual property rights laws are legal-equitable and WTO-compliant.

Govt move of taxing life-saving drugs may boost domestic cos

Indian drug associations say that this hike, which is essentially a withdrawal of exemptions, will have a marginal impact on prices.

Customs duty on drugs irrational; patients will suffer: Biocon

Kiran Mazumdar Shaw, CMD, Biocon, calls this to be an irrational commentary from the government‘s side, as it will only the end-user—the patient—who will have to pay the increased cost.

Biosimilars is the next big thing for generic cos: Biocon

Biocon CMD Kiran Mazumdar-Shaw said the company‘s research efforts are focused on a number of programs that deliver drugs that women can benefit from.